AstraZeneca Year-to-date and Q3 2015 Results
AstraZeneca will announce its results for year-to-date and Q3 2015 on Thursday 5 November 2015 with a scheduled Stock Exchange release time of 07:00GMT (08:00CET, 02:00amEST). The announcement will also be available at www.astrazeneca.com/investors. An accompanying conference call will take place at 12:00GMT (13:00CET, 07:00AM EST) and will be accessible via two routes:
1. Audio webcast
Listeners will be able to pre-register and test the webcast via www.astrazeneca.com/investors from Monday 2 November. During the Q&A session listeners will be able to pose questions to the presenters via e-mail. If you wish to participate in the Q&A session live rather than by e-mail you will need to dial into the conference call; details are shown below.
An indexed version of the webcast will be available from 17:30GMT on Thursday 5 November2015 on http://www.astrazeneca.com/investors/.
2. Conference call
If you wish to listen to the presentation and take part in the Q&A session live, please see the details below:
UK (freephone): 0800 694 2370
International: +44 1452 557749
Sweden (freephone): 0200 883 079
USA (freephone): 866 977 7645
Conference ID: 75218823
To ensure that you don’t miss the start of the conference call please dial into the call five minutes early. The presentation will be available for download on the AstraZeneca Investor Relations website http://www.astrazeneca.com/investors/ 30 minutes before the conference call begins.
American Society of Clinical Oncology (ASCO) Annual Meeting
1 June 2015
AstraZeneca will be hosting a briefing for analysts and investors during the American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago on Monday 1 June 2015, from 8:30pm –10:00pm CDT (2 June 2:30am - 4:00am BST – UK). The aim of this event is to update on progress with AstraZeneca’s immuno-oncology pipeline and combination treatments.
You will be able to listen to the event using the following dial in details:
UK freephone: 0800 694 0257
US freephone: 866 966 9439
Sweden freephone: 0200 890171
International: +44 (0) 1452 555566
Conference code: 42762226